Paydirt
AS
Insider

Alan B. Sandler

Chief Development Officer · Revolution Medicines

Alan B. Sandler (Chief Development Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $1.2M of RVMD (6,008 sh across 4 lots, as filed), executed Sep 29. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.2M
shares × price, as filed
Last traded
Sep 29
Filed Oct 1

Median ADV $548.2M across their filed names

Open performance→
Volume by month
$1.2M$607K$0Dec 2024Jun 2025Dec 2025Jun 2026Oct 2026 · sells $1.2M
Buys $0 Sells $1.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
RVMD Revolution Medicines, Inc. RVMD · 0 buys · 1 sell 1 filing
Recent filings
RVMDSALE Revolution Medicines, Inc. View filing → $1.2M
6,008 sh across 4 lots
Exec Sep 29
Filed Oct 1 · 6:00 PM ET